New York Life Trust’s Thermo Fisher Scientific TMO Stock Holding History

New York Life Trust’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$0	Buy	+2	New	+$306	﹤0.01%	246

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

New York Life Trust's TMO Position: Q1 2017 in Review

New York Life Trust opened a new position in Thermo Fisher Scientific (TMO) in Q1 2017: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #246 among its holdings.

1,135 funds tracked by Wall St. Rank hold TMO as of Q1 2017.

New York Life Trust held 2 shares of Thermo Fisher Scientific worth $0 as of Q1 2017.
Thermo Fisher Scientific was a new New York Life Trust position in Q1 2017.
Thermo Fisher Scientific made up ﹤0.01% of New York Life Trust's portfolio in Q1 2017, its #246 holding.
1,135 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.